ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 617965 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 617965; 2) Community: the network communities that were significantly associated with the response to NSC 617965; 3) Molecule: the relationships between components within communities and NSC 617965; 4) MDR: the compounds that were significantly associated with the NSC 617965.

NSC Compound Enrichment Correlation
NSC 750746 (E)-1-(3,4-dimethoxyphenyl)-3-(2-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl)prop-2-en-1-one 0.0376362543535815 0.23684745
NSC 756619 Null 0.0376362543535815 -0.047737203
NSC 762583 Null 0.0376362543535815 -0.080912108
NSC 622341 Null 0.0382675857669585 0.11410776
NSC 624474 Null 0.0382675857669585 -0.012978152
NSC 625505 Null 0.0382675857669585 0.1180427
NSC 632882 Dicarbonyl[1-(4-cyanaphenyl-NC-azomethyine)- naphthaline-2-olato(O1,N1)]iridium(I) 0.0382675857669585 0.11737649
NSC 639174 Camptothecin Derivative 0.0382675857669585 0.36326264
NSC 639186 Raltitrexed 0.0382675857669585 0.32639737
NSC 645384 Null 0.0382675857669585 0.19706792
Total:114  Current:86    [First] [Prev] [Next] [Last]